Published by Emerging Technologies Laboratory · via ETL Newswire
Health· 

Bangladesh Measles Death Toll Tops 1,000 Children After Vaccination Drive Falls Short

A vaccine supply collapse rooted in political turmoil left roughly four million children unprotected, and an emergency campaign launched in April hasn't been enough to stop the spread.

By Karen Bishop, Correspondent · Health Desk

More than 1,000 children have now died in Bangladesh's measles outbreak, and officials acknowledge that the emergency vaccination campaign launched in April didn't reach everyone it needed to.

According to figures reported by Al Jazeera on September 9, the death toll among children had just surpassed 1,000. The Directorate General of Health Services put the total suspected and confirmed case count at more than 168,000 as of September 10, with nearly 20,000 laboratory-confirmed infections, according to figures cited by Wikipedia's entry on the 2026 Bangladesh measles outbreak.

The population most at risk couldn't be more vulnerable. According to a WHO disease outbreak notice reviewed for this article, roughly 79% of reported cases are children under five years old, including infants under nine months who are generally too young to receive routine measles vaccination under standard schedules. Most deaths, WHO noted, have occurred among unvaccinated children younger than two years.

This isn't a case of a vaccine that failed. It's a case of vaccines that never arrived. According to reporting reviewed from Think Global Health, Bangladesh typically procures about 70 million doses per year, but only 17.8 million doses were secured in 2025 through UNICEF's pre-financing mechanism. A nationwide vaccination campaign planned for late 2024 was postponed and then canceled outright, leaving millions of toddlers unprotected when the outbreak began.

The WHO and UNICEF have linked the crisis to immunization program gaps that opened in 2024 and 2025, during the political turmoil following the ousting of then-Prime Minister Sheikh Hasina, according to Al Jazeera's coverage. Bangladesh's Health Minister told parliament that changes to procurement policy during that period created the shortage that preceded the outbreak.

In response, national authorities launched a phased emergency vaccination drive beginning April 5, initially in 30 high-risk sub-districts and later expanded nationwide. Authorities also lowered the minimum vaccination age to six months, below the routine schedule of nine months, consistent with WHO guidance for outbreak settings. That campaign ultimately vaccinated 18 million children. But official figures show roughly four million were never reached. DGHS spokesman Zahid Raihan told the AFP news agency that teams were still searching for those missed children.

For families inside Bangladesh's hospitals, the numbers are not abstract. Think Global Health documented the experience of a mother in Dhaka Shishu Hospital's measles ward in May, sitting beside her seven-month-old daughter who had been admitted a week earlier and struggled to breathe overnight.

A rapid situation analysis published on arXiv in April described Bangladesh as a country that had been close to measles-rubella elimination before the outbreak began. The resurgence, the analysis concluded, reflects accumulated immunity gaps rather than vaccine failure, driven by subnational inequities and program disruptions.

That's a distinction worth holding onto. The measles-mumps-rubella vaccine works. Two doses produce roughly 97% protection. What's on display in Bangladesh is what happens when procurement breaks down, campaigns get canceled, and political instability is allowed to eat into public health infrastructure that took decades to build.

A peer-reviewed commentary in BMC's International Journal of Infectious Diseases drew an uncomfortable parallel, noting that U.S. two-dose MMR coverage at school entry has slipped from 95.2% in 2019-2020 to 92.7% in 2023-2024, and that 93% of the 1,958 U.S. measles cases recorded in 2025 occurred in people who were unvaccinated or of unknown vaccination status. The authors warned that without firmer school-entry requirements, decades of U.S. elimination gains may not be stable.

Bangladesh's cabinet approved a return to direct procurement through UNICEF in June 2026 to stabilize its supply chain, according to Think Global Health. Whether that comes in time to close the remaining immunity gap is still an open question.

Sources cited:
- Al Jazeera (https://www.aljazeera.com/news/2026/9/9/bangladesh-measles-deaths-pass-1000-as-vaccination-drive-falls-short)
- WHO Disease Outbreak Notice, Measles, Bangladesh (https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON598)
- Think Global Health, Visualizing Bangladesh's Measles Outbreak (https://www.thinkglobalhealth.org/article/visualizing-bangladeshs-massive-measles-outbreak)
- arXiv, Measles Resurgence in Bangladesh, 2026: A Situational Analysis (https://arxiv.org/html/2604.25951v1)
- International Journal of Infectious Diseases, Re-Evaluating Global Measles Management (https://pmc.ncbi.nlm.nih.gov/articles/PMC13267961/)
- Wikipedia, 2026 Bangladesh measles outbreak (https://en.wikipedia.org/wiki/2026_Bangladesh_measles_outbreak)

Reporting by Karen Bishop, Correspondent, for the Health desk · ETL Newswire staff
Read more at the source

This release was originally distributed via ETL Newswire. Visit Al Jazeera for the full story, related releases, and contact information.

Visit Al Jazeera →